Antiplatelet and Anticoagulation Therapy in Vitreoretinal Surgery
Authors:
- William E. SmiddyWSWilliam E. Smiddy
- Sung Soo KimSKSung Soo Kim
- 1 June 2011
- journal article
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 151 (6) , 934-939.e3
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Atrial fibrillation, stroke prevention therapy and agingNature Reviews Cardiology, 2009
- The Cataract National Dataset electronic multicentre audit of 55 567 operations: antiplatelet and anticoagulant medicationsEye, 2008
- ANTICOAGULATION WITH WARFARIN IN VITREORETINAL SURGERYRetina, 2007
- Perioperative use of warfarin and aspirin in cataract surgery by Canadian Society of Cataract and Refractive Surgery members: SurveyJournal of Cataract & Refractive Surgery, 2005
- Low‐dose aspirin for secondary cardiovascular prevention – cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation – review and meta‐analysisJournal of Internal Medicine, 2005
- Risks and benefits of anticoagulant and antiplatelet medication use before cataract surgeryOphthalmology, 2003
- A Randomized Trial of Aspirin to Prevent Colorectal AdenomasNew England Journal of Medicine, 2003
- A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)The Lancet, 1996
- Aspirin and the Risk of Colorectal Cancer in WomenNew England Journal of Medicine, 1995
- Clustering of cardiovascular risk factors: Targeting high-risk individualsThe American Journal of Cardiology, 1995